Pretreatment serum microRNA-122 is not predictive for treatment response in chronic hepatitis C virus infection

Digestive and Liver Disease

Volumn 44, Issue 5, 2012, Pages 438-441

  Waidmann, Oliver ^a   Bihrer, Verena ^a   Kronenberger, Bernd ^a   Zeuzem, Stefan ^a   Piiper, Albrecht ^a   Forestier, Nicole ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Antiviral therapy; Hepatitis C; MicroRNA 122; MicroRNAs

Indexed keywords

MICRORNA; MICRORNA 122; MICRORNA 16; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RIBAVIRIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; RNA EXTRACTION; TREATMENT RESPONSE;

ADULT; AGED; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; BIOLOGICAL MARKERS; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; MICRORNAS; MIDDLE AGED; POLYETHYLENE GLYCOLS; REAL-TIME POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBAVIRIN;

EID: 84859213566     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2011.11.011     Document Type: Article

References (23)

1. Seeff L.B. Natural history of chronic hepatitis C. Hepatology 2002, 36:S35-S46.
2. Poordad F., McCone J., Bacon B.R., et al. Boceprevir for untreated chronic HCV genotype 1 infection. N Engl J Med 2011, 364:1195-1206.
3. Jacobson I.M., McHutchison J.G., Dusheiko G., et al. Telaprevir for previously untreated chronic hepatitis C virus infection. N Engl J Med 2011, 364:2405-2416.
4. Kau A., Vermehren J., Sarrazin C. Treatment predictors of a sustained virologic response in hepatitis B and C. J Hepatol 2008, 49:634-651.
5. Sarrazin C., Berg T., Ross R.S., et al. Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection. Z Gastroenterol 2010, 48:289-351.
6. Lange C.M., Zeuzem S. IL28B single nucleotide polymorphisms in the treatment of hepatitis C. J Hepatol 2011, 55:692-701.
7. Bihrer V., Friedrich-Rust M., Kronenberger B., et al. Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection. Am J Gastroenterol 2011, 106:1663-1669.
8. Zhang Y., Jia Y., Zheng R., et al. Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases. Clin Chem 2010, 56:1830-1838.
9. Ambros V. The functions of animal microRNAs. Nature 2004, 431:350-355.
10. Chen X., Ba Y., Ma L., et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008, 18:997-1006.
11. Zen K, Zhang CY. Circulating MicroRNAs: a novel class of biomarkers to diagnose and monitor human cancers. Med Res Rev 2010 [November, Epub ahead of print].
12. Lagos-Quintana M., Rauhut R., Yalcin A., et al. Identification of tissue-specific microRNAs from mouse. Curr Biol 2002, 12:735-739.
13. Chang J., Nicolas E., Marks D., et al. miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. RNA Biol 2004, 1:106-113.
14. Sarasin-Filipowicz M., Krol J., Markiewicz I., et al. Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy. Nat Med 2009, 15:31-33.
15. Turchinovich A., Weiz L., Langheinz A., et al. Characterization of extracellular circulating microRNA. Nucleic Acids Res 2011, 39:7223-7233.
16. Ishak K., Baptista A., Bianchi L., et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995, 22:696-699.
17. Asaga S., Kuo C., Nguyen T., et al. Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer. Clin Chem 2011, 57:84-91.
18. Marquez R.T., Bandyopadhyay S., Wendlandt E.B., et al. Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans. Lab Invest 2010, 90:1727-1736.
19. Murakami Y., Yasuda T., Saigo K., et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 2006, 25:2537-2545.
20. Morita K., Taketomi A., Shirabe K., et al. Clinical significance and potential of hepatic microRNA-122 expression in hepatitis C. Liver Int 2011, 31:474-484.
21. ClinicalTrials.gov Identifier: ctgov:NCT00980161.
22. Jopling C.L., Yi M., Lancaster A.M., et al. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 2005, 309:1577-1581.
23. Lanford R.E., Hildebrandt-Eriksen E.S., et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 2010, 327:198-201.